Related references
Note: Only part of the references are listed.qvality: non-parametric estimation of q-values and posterior error probabilities
Lukas Kall et al.
BIOINFORMATICS (2009)
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects
P. Monteleone et al.
GENES BRAIN AND BEHAVIOR (2009)
Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study
S. W. van den Berg et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter
Christopher J. Ott et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
S. Le Hellard et al.
MOLECULAR PSYCHIATRY (2009)
Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients
Riccardo Sarzani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers
Harri Makkonen et al.
NUCLEIC ACIDS RESEARCH (2009)
Variants in the CNR1 and the FAAH Genes and Adiposity Traits in the Community
Wolfgang Lieb et al.
OBESITY (2009)
The incentive salience of alcohol - Translating the effects of genetic variant in CNR1
Kent E. Hutchison et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population
Janaina P. Jaeger et al.
DISEASE MARKERS (2008)
Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations
Michael Benzinou et al.
HUMAN MOLECULAR GENETICS (2008)
The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain
Katrina Weston-Green et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System
Blerina Kola et al.
PLOS ONE (2008)
Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index
Tes M. Baye et al.
PHARMACOGENOMICS (2008)
Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa
Timo Müller et al.
Child and Adolescent Psychiatry and Mental Health (2008)
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
H. A. Nasrallah
MOLECULAR PSYCHIATRY (2008)
Association of the HTR2C gene and antipsychotic induced weight gain:: a meta-analysis
Vincenzo De Luca et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men
Paola Russo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population
P. Gazzerro et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet
J. Aberle et al.
HORMONE AND METABOLIC RESEARCH (2007)
No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents
Timo Dirk Mueller et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men
Armand Peeters et al.
ENDOCRINE (2007)
Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors
Stephen C. Woods
AMERICAN JOURNAL OF MEDICINE (2007)
Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus
Priscilla Hollander
AMERICAN JOURNAL OF MEDICINE (2007)
Endocannabinoids and the control of energy balance
Isabel Matias et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Genetics of antipsychotic treatment emergent weight gain in schizophrenia
Daniel J. Mueller et al.
PHARMACOGENOMICS (2006)
Suggestive association between the C825T polymorphism of the G-protein β3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia
DJ Müller et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
KM Gamber et al.
NEUROPHARMACOLOGY (2005)
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia
DJ Müller et al.
NEUROSCIENCE LETTERS (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
CR Trillou et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Regulatory interaction between arylhydrocarbon receptor and SIM1, two basic helix-loop-helix PAS proteins involved in the control of food intake
C Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa:: Differences between restricting and bingeing/purging subtypes
Z Siegfried et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Human cannabinoid receptor 1:: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse
PW Zhang et al.
MOLECULAR PSYCHIATRY (2004)
Pedigree disequilibrium tests for multilocus haplotypes
F Dudbridge
GENETIC EPIDEMIOLOGY (2003)
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
D Cota et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
CR Trillou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
-759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain
SJ Tsai et al.
LANCET (2002)
Deletion of the SIM1 gene (6q 16.2) in a patient with a Prader-Willi-like phenotype
L Faivre et al.
JOURNAL OF MEDICAL GENETICS (2002)
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
TC Kirkham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
J Volavka et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
N Jamshidi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus
JL Michaud et al.
HUMAN MOLECULAR GENETICS (2001)
Leptin-regulated endocannabinoids are involved in maintaining food intake
V Di Marzo et al.
NATURE (2001)
Share Paper
